Drugs / LNP.UCD.ABE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07667387 | Jul 2026 → Jul 2028 expected | carbamoyl phosphate synthetase I deficiency disease | Rebecca Ahrens-Nicklas | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LNP.UCD.ABE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07667387 ↗ |